Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
4542217016 | Relugolix-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
4542218014 | Product containing relugolix (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Relugolix-containing product | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Some | ||
Relugolix-containing product | Is a | agent antinéoplasique | false | Inferred relationship | Some | ||
Relugolix-containing product | Is a | Product containing gonadotropin releasing hormone receptor antagonist (product) | true | Inferred relationship | Some | ||
Relugolix-containing product | Is a | Medicinal product categorized by structure | true | Inferred relationship | Some | ||
Relugolix-containing product | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Relugolix (substance) | true | Inferred relationship | Some | 1 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Product containing only relugolix (medicinal product) | Is a | True | Relugolix-containing product | Inferred relationship | Some | |
Product containing relugolix in oral dose form (medicinal product form) | Is a | True | Relugolix-containing product | Inferred relationship | Some |
Reference Sets
Description inactivation indicator reference set